IMHA Dosage & Thromboprophylaxis Calculators
Rapidly calculate tailored acute-stage and maintenance immunosuppressive regimens alongside mandatory, guideline-backed antithrombotic therapies. Select your patient's species below to access optimised clinical worksheets.
Canine Calculator
Derived strictly from the 2019 ACVIM Consensus Guidelines for Dogs. Configured with a built-in safety ceiling of 60 mg/day max daily prednisone cap to mitigate massive corticosteroid toxicity risks in larger sizes.
- ✓ Prednisone / Prednisolone
- ✓ Mycophenolate Mofetil
- ✓ Clopidogrel & Rivaroxaban
Feline Calculator
Formulated with mandatory feline specific guidelines. Highlights strict warnings regarding lethal bone marrow suppressors (Azathioprine) and offers standard flat and weight-based clot prevention protocols.
- ✓ Prednisolone PO BID
- ✓ Mycophenolate Mofetil
- ✓ Flat Clopidogrel (18.75mg)
Equine Calculator
Formulated specifically for large animal medicine. Avoids oral prednisone pathways, structures acute IV dexamethasone limits, and provides crucial warning parameters regarding high-risk corticosteroid-induced Laminitis.
- ✓ Dexamethasone IV q24h
- ✓ Unfractionated/LMWH Heparin
- ✓ Laminitis & Pulse Advisory
Thrombosis represents a leading cause of mortality in canine, feline, and equine IMHA patients. Antithrombotic regimens should be initialized concurrently with the first corticosteroid dose.
To prevent catastrophic hemorrhaging, clinicians should select and administer either a direct anticoagulant (e.g., Rivaroxaban or Heparin) or an antiplatelet inhibitor (e.g., Clopidogrel or Aspirin). Combining therapeutic drug pathways should only be handled within advanced ICU or specialist monitoring settings.